Evidence map›Paper›PMID 40203077›Full record

ArticleBioinformatics (Oxford, England)2025

Finding antibodies in cryo-EM maps with CrAI.

Vincent Mallet, Chiara Rapisarda, Hervé Minoux, Maks Ovsjanikov

Erratum issuedAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Vincent MalletLIX, Ecole Polytechnique, IPP Paris, Palaiseau, 91120, France.ORCID 0000-0003-4664-754X
Chiara RapisardaIntegrated Drug Discovery, Structural Biology and Biophysics, Sanofi, Vitry-sur-Seine, 94400, France.
Hervé MinouxIntegrated Drug Discovery, Structural Biology and Biophysics, Sanofi, Vitry-sur-Seine, 94400, France.
Maks OvsjanikovLIX, Ecole Polytechnique, IPP Paris, Palaiseau, 91120, France.

Funding

IDRIS AD010613356R1
6 · The paper itself

Abstract

motivationTherapeutic antibodies have emerged as a prominent class of new drugs due to their high specificity and their ability to bind to several protein targets. Once an initial antibody has been identified, its design and characteristics are refined using structural information, when it is available. Cryo-EM is currently the most effective method to obtain 3D structures. It relies on well-established methods to process raw data into a 3D map, which may, however, be noisy and contain artifacts. To fully interpret these maps the number, position, and structure of antibodies and other proteins present must be determined. Unfortunately, existing automated methods addressing this step have limited accuracy, require additional inputs and high-resolution maps, and exhibit long running times.

resultsWe propose the first fully automatic and efficient method dedicated to finding antibodies in cryo-EM maps: CrAI. This machine learning approach leverages the conserved structure of antibodies and a dedicated novel database that we built to solve this problem. Running a prediction takes only a few seconds, instead of hours, and requires nothing but the cryo-EM map, seamlessly integrating within automated analysis pipelines. Our method can find the location and pose of both Fabs and VHHs at resolutions up to 10 Å and is significantly more reliable than existing approaches. AVAILABILITY AND IMPLEMENTATION: We make our method available both in open source github.com/Sanofi-Public/crai and as a ChimeraX bundle (crai).

Indexed as

AntibodiesCryoelectron MicroscopyMachine LearningModels, MolecularProtein ConformationSoftwareAntibodies

Identifiers

PMID40203077
PMCPMC12077295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.